Study observes reduced cell viability in 3T3 fibroblast cells with chitosan diluents, suggesting limited biocompatibility of materials.
Purpose: The present study evaluates the cytocompatibility of chitosan (CS)-modified glass ionomer cement (GIC) diluents for a Balb/c 3T3 fibroblast cell line. Methods: Three different commercially available hand-mix GIC materials were used in this experiment: Fuji IX GP, Ketac Universal, and Riva Self Cure. The diluents for cell viability tests were produced from DMEM exposed to sterile CS-modified glass ionomer material specimens for three different time periods (0–1, 1–7, and 7–21 days). The resultant diluents were exposed to a 3T3 fibroblast cell line using the indirect contact technique in 96-well plates. In order to assess the physical cell response, five material specimens (1 mm high and 3 mm in diameter) of each material (n = 45) were produced and 3T3 cells were seeded on the specimens. SEM evaluation of the cells was conducted. Results: All the Ketac Universal materials resulted in a decrease in cell viability on day 1. Fuji IX and the CS-modified GICs are the most consistent regarding cell viability. None of the CS-modified GICs exhibited improved cumulative cell biocompatibility. Conclusion: Two materials—Riva Self Cure modified with 5% and 10% CS—retained a decreased cell viability at day 21 compared to the viability of 3T3 cells exposed to the control DMEM.
No takes yet. Share an insight, caveat, or question.
Mulder et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: